Ralf Clemens

Ralf Leo Clemens currently works at Mindfactory AG, as Chairman-Supervisory Board, African Research Excellence Fund, as Director from 2017, CureVac SE, as Member-Supervisory Board, and International Vaccine Institute, as Trustee.
Dr. Clemens also formerly worked at Clover Biopharmaceuticals Ltd., as Non-Executive Director from 2022 to 2025, Meininger Verlag GmbH, as Co-Managing Director, CureVac NV, as Member-Supervisory Board from 2016 to 2023, Takeda Pharmaceutical Co., Ltd., as Senior Vice President-Research & Development from 2012 to 2015, Takeda Pharmaceuticals International, Inc., as Senior Vice President & Head-Development from 2012 to 2014, Novartis Vaccines & Diagnostics Srl, as Head-Global Vaccines Development from 2006 to 2012, Valneva SE, as Independent Member-Supervisory Board from 2016 to 2019, and Gsk Biologicals, as Head-Vaccine Development & Latin American Business from 1992 to 2006.
Dr. Clemens received his doctorate degree from The Johannes Gutenberg University of Mainz and undergraduate degree from The Wharton School of the University of Pennsylvania.